JG
ARNA

Jefferies Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Jefferies Group’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-15,100
Closed -$1.4M – 2110
2021
Q4 		$1.4M Sell
15,100
-9,700
-39% -$639K 0.01% 902
2021
Q3 		$1.48M Buy
+24,800
New +$1.46M 0.01% 854
2018
Q3 		– Sell
-12,000
Closed -$523K – 2858
2018
Q2 		$523K Buy
+12,000
New +$516K ﹤0.01% 1567

Jefferies Group's ARNA Position: Q1 2022 in Review

Jefferies Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 121,719 shares — an estimated $11.3M sold.

Jefferies Group first reported a position in ARNA in Q2 2013 and held it in 5 quarters. The position peaked at $11.3M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Jefferies Group reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Jefferies Group sold 121,719 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $11.3M.
  • Jefferies Group first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 5 quarters.
  • Jefferies Group's Arena Pharmaceuticals Inc position peaked at $11.3M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Jefferies Group's 13F filing for Q1 2022, filed 16 May 2022.